NIH Human Embryonic Stem Cell Registry - Research Using These Lines is Eligible for NIH Funding

COVID-19

Expand for resources

n/a Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.

Detailed information for selected cell line:

Cell Line:	HAD-C 106
NIH Registration Number:	0125
NIH Approval Number:	NIHhESC-11-0125
Available for Distribution:	Yes
Provider Restrictions:	Available for non-clinical research subject to an MTA that specifies the proposed research and includes a commitment to handle the stem cells ethically. Possible availability for clinical use subject to a review of the research proposal, ethical, and regulatory approvals.
Additional Information:	(None)
NIH Restrictions:	(No Additional Restrictions)
Submitting Organization:	Hadassah Hebrew University Medical Center
Provider Name:	Benjamin E. Reubinoff
Provider Phone:	011-972-507-874-569
Provider Email:	benjaminr@ekmd.huji.ac.il
Provider URL:	https://www.hadassah.org.il/en/gene_therapy_center_for_hereditary_diseases/
Approval Date:	06/16/2011

Related Resources

hESC Line Listings:

NIH Form 2890:

Stem Cell Information:

RSS Feed:

Contact Us: